341 related articles for article (PubMed ID: 30857524)
21. YTHDF1 Regulates Pulmonary Hypertension through Translational Control of MAGED1.
Hu L; Wang J; Huang H; Yu Y; Ding J; Yu Y; Li K; Wei D; Ye Q; Wang F; Shen B; Chen J; Fulton DJR; Chen F
Am J Respir Crit Care Med; 2021 May; 203(9):1158-1172. PubMed ID: 33465322
[No Abstract] [Full Text] [Related]
22. Long noncoding RNA UCA1 promotes the proliferation of hypoxic human pulmonary artery smooth muscle cells.
Zhu TT; Sun RL; Yin YL; Quan JP; Song P; Xu J; Zhang MX; Li P
Pflugers Arch; 2019 Feb; 471(2):347-355. PubMed ID: 30353369
[TBL] [Abstract][Full Text] [Related]
23. Modulation of Pulmonary Vascular Remodeling in Hypoxia: Role of 15-LOX-2/15-HETE-MAPKs Pathway.
Yu X; Li T; Liu X; Yu H; Hao Z; Chen Y; Zhang C; Liu Y; Li Q; Mao M; Zhu D
Cell Physiol Biochem; 2015; 35(6):2079-97. PubMed ID: 25895668
[TBL] [Abstract][Full Text] [Related]
24. Baicalin inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via the AKT/HIF-1α/p27-associated pathway.
Zhang L; Pu Z; Wang J; Zhang Z; Hu D; Wang J
Int J Mol Sci; 2014 May; 15(5):8153-68. PubMed ID: 24821539
[TBL] [Abstract][Full Text] [Related]
25. Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1.
Sysol JR; Chen J; Singla S; Zhao S; Comhair S; Natarajan V; Machado RF
Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L461-L472. PubMed ID: 29167124
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension.
Li Y; Ren W; Wang X; Yu X; Cui L; Li X; Zhang X; Shi B
Biomed Pharmacother; 2019 Jan; 109():1740-1749. PubMed ID: 30551428
[TBL] [Abstract][Full Text] [Related]
27. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.
Xu Y; Sun Z; Wang Q; Wang T; Liu Y; Yu F
Vascul Pharmacol; 2019 Sep; 120():106568. PubMed ID: 31207359
[TBL] [Abstract][Full Text] [Related]
28. Fluorofenidone attenuates vascular remodeling in hypoxia-induced pulmonary hypertension of rats.
Li XW; Du J; Hu GY; Hu CP; Li D; Li YJ; Li XH
Can J Physiol Pharmacol; 2014 Jan; 92(1):58-69. PubMed ID: 24383874
[TBL] [Abstract][Full Text] [Related]
29. Soluble JAGGED1 inhibits pulmonary hypertension by attenuating notch signaling.
Xiao Y; Gong D; Wang W
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2733-9. PubMed ID: 24072692
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA let-7g inhibited hypoxia-induced proliferation of PASMCs via G
Zhang WF; Xiong YW; Zhu TT; Xiong AZ; Bao HH; Cheng XS
Life Sci; 2017 Feb; 170():9-15. PubMed ID: 27889560
[TBL] [Abstract][Full Text] [Related]
31. Involvement of CapG in proliferation and apoptosis of pulmonary arterial smooth muscle cells and in hypoxia-induced pulmonary hypertension rat model.
Xu X; Hu H; Wang X; Ye W; Su H; Hu Y; Dong L; Zhang R; Ying K
Exp Lung Res; 2016 Apr; 42(3):142-53. PubMed ID: 27093378
[TBL] [Abstract][Full Text] [Related]
32. Mitofusin 2 Downregulation Triggers Pulmonary Artery Smooth Muscle Cell Proliferation and Apoptosis Imbalance in Rats With Hypoxic Pulmonary Hypertension Via the PI3K/Akt and Mitochondrial Apoptosis Pathways.
Fang X; Chen X; Zhong G; Chen Q; Hu C
J Cardiovasc Pharmacol; 2016 Feb; 67(2):164-74. PubMed ID: 26485208
[TBL] [Abstract][Full Text] [Related]
33. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
34. Critical role of VGLL4 in the regulation of chronic normobaric hypoxia-induced pulmonary hypertension in mice.
Tian Q; Fan X; Ma J; Li D; Han Y; Yin X; Wang H; Huang T; Wang Z; Shentu Y; Xue F; Du C; Wang Y; Mao S; Fan J; Gong Y
FASEB J; 2021 Aug; 35(8):e21822. PubMed ID: 34314061
[TBL] [Abstract][Full Text] [Related]
35. A Critical Role of the mTOR/eIF2α Pathway in Hypoxia-Induced Pulmonary Hypertension.
Wang AP; Li XH; Yang YM; Li WQ; Zhang W; Hu CP; Zhang Z; Li YJ
PLoS One; 2015; 10(6):e0130806. PubMed ID: 26120832
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-214-3p Regulates Hypoxia-Mediated Pulmonary Artery Smooth Muscle Cell Proliferation and Migration by Targeting ARHGEF12.
Xing XQ; Li B; Xu SL; Liu J; Zhang CF; Yang J
Med Sci Monit; 2019 Aug; 25():5738-5746. PubMed ID: 31373336
[TBL] [Abstract][Full Text] [Related]
37. MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1.
Zhao TF; Wang SY; Zou XZ; Zhao HD
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3495-3502. PubMed ID: 31081105
[TBL] [Abstract][Full Text] [Related]
38. LncRNA PAXIP1-AS1 fosters the pathogenesis of pulmonary arterial hypertension via ETS1/WIPF1/RhoA axis.
Song R; Lei S; Yang S; Wu SJ
J Cell Mol Med; 2021 Aug; 25(15):7321-7334. PubMed ID: 34245091
[TBL] [Abstract][Full Text] [Related]
39. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model.
Pak O; Sommer N; Hoeres T; Bakr A; Waisbrod S; Sydykov A; Haag D; Esfandiary A; Kojonazarov B; Veit F; Fuchs B; Weisel FC; Hecker M; Schermuly RT; Grimminger F; Ghofrani HA; Seeger W; Weissmann N
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):358-67. PubMed ID: 23590303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
